After a sharp selloff that pushed the Nifty below the psychological 24,000 mark for the first time in weeks, Indian equity benchmarks staged a strong comeback on Monday, April 27. The BSE Sensex soared 639 points to close at 77,304, while the Nifty advanced 195 points to settle at 24,093—snapping a three-session losing streak in style.
Investors gained approximately ₹6.6 trillion in wealth as the total market capitalisation of BSE-listed companies jumped to ₹468.11 trillion, up from ₹461.49 trillion in the previous session. But what fueled this sharp rebound? And what does the road ahead look like for Indian markets? Let’s dive deep.
Table of Contents
- BSE Sensex Today: Key Numbers at a Glance
- Reasons Behind Today’s Market Rally
- Top Gainers: Sun Pharma, RIL Steal the Show
- Top Losers: Axis Bank, Shriram Finance Bleed
- Sectoral Performance: Pharma Shines, Banks Struggle
- Global Market Cues: Asian Peers Lead the Way
- Crude Oil Fears: The Elephant in the Room
- FIIs vs DIIs: Who is Buying and Selling?
- Technical Outlook: What Analysts Are Saying
- Looking Ahead: Key Triggers for the Coming Days
- Final Verdict: Bottom Line
BSE Sensex Today: Key Numbers at a glance {#key-numbers}
Metric | Value |
Sensex Close | 77,303.63 (+639.42 pts / +0.83%) |
Nifty Close | 24,092.70 (+194.75 pts / +0.81%) |
Intraday Sensex High | 77,420.04 (+755.83 pts / +0.98%) |
Intraday Nifty High | 24,129.55 (+231.6 pts / +0.97%) |
Market Breadth (BSE) | 3,072 advances vs 1,240 declines |
India VIX | ~18.56 (down ~6%, indicating easing volatility) |
Market Cap | ₹468.11 trillion (₹6.6 trillion added) |
The Sensex, which had closed Friday’s session at 76,664.21, opened at 76,856.05 and gained momentum through the day. Afternoon trade saw the index jump 703 points to 77,367 before settling near the day’s highs.
Reasons Behind Today’s Market Rally {#reasons-rebound}
The sharp upmove on Monday was driven by a confluence of domestic and global catalysts that overshadowed lingering headwinds. Here are the top four factors that fueled the rebound:
1. Easing Geopolitical Concerns Over West Asia
While US-Iran peace talks hit a temporary roadblock—President Trump cancelled a scheduled meeting with Tehran’s delegation in Islamabad—renewed signs of engagement emerged over the weekend. Iran reportedly proposed a fresh plan through Pakistani mediators to reopen the Strait of Hormuz and end the ongoing conflict. Although Trump cancelled the meeting citing “tremendous infighting and confusion within their leadership,” hopes of a diplomatic resolution kept global risk appetite afloat.
“Developments around the Strait of Hormuz, including Iran’s recent overtures, have offered some relief, but uncertainty surrounding stalled US-Iran negotiations is keeping risk appetite in check,” said Ponmudi R, CEO of Enrich Money.
2. India–New Zealand Free Trade Agreement (FTA)
In a major domestic boost, India and New Zealand formally signed their Free Trade Agreement at Bharat Mandapam in New Delhi on Monday. Under the pact, all 8,284 Indian export products will receive duty-free access to the New Zealand market, with a goal to increase bilateral trade to $5 billion over the next five years.
The agreement is expected to benefit a wide range of Indian industries, from textiles and pharmaceuticals to engineering goods and agriculture—infusing fresh optimism into export-oriented sectors.
3. Sun Pharma’s Landmark Organon Acquisition
In one of the largest outbound acquisitions by an Indian pharmaceutical company, Sun Pharma announced it would acquire US-listed drugmaker Organon & Co. in an all-cash transaction valued at $11.75 billion (₹14.00 per share). The deal catapults Sun Pharma into the top 25 global pharmaceutical companies, with a combined revenue of roughly $12.4 billion. It also positions the company as a top-3 global player in Women’s Health and the 7th-largest global biosimilar player.
The announcement triggered a 6-7% rally in Sun Pharma’s stock—which emerged as the top Sensex gainer—and lifted the entire pharmaceutical sector.
4. Broad-Based Buying Amid Q4 Earnings Season
Market participants rushed to accumulate quality stocks after Friday’s sharp correction, which was driven largely by extreme pessimism rather than a fundamental deterioration in the earnings outlook. Value buying emerged across banking, IT, metals, and realty counters. As Vinod Nair, Head of Research at Geojit Investment, noted:
“Although oil prices remain above $100 per barrel and markets continue to assess the room for opening of the Strait of Hormuz, domestic-oriented sectors—particularly banking, FMCG, capital goods, consumer discretionary, and manufacturing-related businesses—supported the recovery.”
Top Gainers: Sun Pharma, RIL Steal the Show {#top-gainers}
Monday’s rally was led by heavyweight stocks with strong earnings momentum or transformative news.
On the Sensex / Nifty:
Stock | Closing Price | % Gain | Reason |
Sun Pharma | ₹1,731.00 | +6.83% | Organon acquisition announced |
Jio Financial Services | ₹254.60 | +3.61% | NBFC licence approval from RBI |
Reliance Industries | N/A | +3.18% | Steady Q4 results; positive brokerage commentary |
Wipro | N/A | +2.82% | IT sector rebound after undervaluation |
Tech Mahindra | N/A | +2.91% | IT sector recovery play |
Adani Ports | ₹1,621.90 | +2.27% | Infrastructure / trade optimism from India–NZ FTA |
JSW Steel | ₹1,292.70 | +2.95% | Metal sector upmove |
Sun Pharma was the undisputed star of the session, rallying from its previous close of ₹1,620.40 to hit an intraday high of ₹1,735. The Organon deal—the largest acquisition by an Indian drugmaker—signals a strategic pivot towards global expansion in high-margin segments.
Among midcaps, Mahindra & Mahindra Financial Services rose nearly 8% after strong Q4 earnings, while One Mobikwik Systems surged over 11% after receiving RBI approval for an NBFC licence.
NHPC: Another High-Volume Gainer
NHPC witnessed extraordinary trading activity, with more than 30 crore shares changing hands on Monday. Although specific company‑specific news remained limited, the stock attracted significant investor attention, possibly linked to renewed interest in the power sector ahead of the summer season.
Top Losers: Axis Bank, Shriram Finance Bleed {#top-losers}
As broad markets rallied, certain stocks bucked the trend—primarily those whose quarterly earnings failed to impress investors.
Stock | % Decline | Reason |
Shriram Finance | -3.69% | Weak Q4 earnings — profit growth missed estimates |
Axis Bank | -2.97% | Flat Q4 profit (+0.6% YoY); provisions spiked 159% |
Bharat Electronics (BEL) | -1.90% | Profit booking after recent run-up |
Tata Consumer Products | -1.19% | Weak quarterly outlook |
Paytm (One97 Communications) | -0.83% | RBI cancelled Paytm Payments Bank licence |
Axis Bank’s quarterly results triggered heavy selling pressure. While net interest income grew 4.7% YoY to ₹14,457 crore, a sharp spike in provisions (up 159% YoY to ₹3,522 crore) and a trading loss weighed heavily on profitability. The stock closed at ₹1,325.40, down nearly 3% for the day.
Shriram Finance, which also announced sub‑par quarterly numbers, fell nearly 4%—making it the worst performer among Nifty constituents.
Sectoral Performance: Pharma Shines, Banks Struggle {#sector-performance}
All 11 key sectoral indices ended Monday’s session in positive territory—a testament to the broad‑based nature of the buying. Here’s how the major sectors performed:
Nifty Pharma (+2.62%): Outperformed all peers. Led by Sun Pharma’s acquisition rally, the index hit a one‑month high. Cohance Life Sciences hit the 20% upper circuit after naming Umang Vohra as Executive Chairman, while Blue Jet Healthcare and Supriya Lifescience also posted strong gains.
Nifty IT: Recovered after last week’s drubbing. Tech Mahindra (+2.91%), Wipro (+2.82%), and TCS (+2.19%) led the pack. Vinod Nair noted that despite subdued results, IT stocks attracted interest due to valuation comfort and long‑term accumulation strategies.
Nifty Metal: Gained around 1.5–2% on expectations of demand revival post the India–NZ FTA. Hindalco, JSW Steel, and Tata Steel were among the top movers.
Nifty Midcap (+1.47%) & Nifty Smallcap (+0.90%): Broader markets also participated enthusiastically. Over 2,500 stocks on the NSE closed in the green.
Nifty Bank (+0.25%): Lagged behind other sectors. Gains in Kotak Mahindra Bank and SBI were offset by sharp declines in Axis Bank and ICICI Bank.
Realty & Consumer Durables: Both gained over 1% each, driven by India–NZ FTA optimism and summer demand expectations.
Air‑Conditioner Makers: Outperformed after the IMD issued a heatwave alert. Blue Star rose over 5% on expectations of strong summer demand.
Global Market Cues: Asian Peers Lead the Way {#global-cues}
Indian markets drew positive cues from Asian peers that traded firmly in the green. Japan’s Nikkei 225 added 1.4% to hit a record high, while South Korea’s Kospi jumped 1.83% to scale a new peak. China’s CSI 300 gained 0.25% after industrial profits jumped 15.8% year-on-year in March, accelerating from 15.2% in January–February.
In the US, Friday’s session witnessed strong closes: the S&P 500 rose 0.8% to 7,165.08, and the Nasdaq Composite jumped 1.63% to 24,836.60, both hitting fresh intraday highs. However, the Dow Jones slipped 0.16% to 49,230.71.
The GIFT Nifty Signal
Before the market opened, the GIFT Nifty was trading around 24,140–24,150 levels, indicating a premium of nearly 170–185 points over Friday’s Nifty futures close, which correctly signaled a gap‑up opening.
Crude Oil Fears: The Elephant in the Room {#crude-oil}
Despite the market rally, crude oil prices surged sharply, posing a significant risk to India’s import-dependent economy.
Brent crude rose 2.42% to $107.87 per barrel, briefly touching a more‑than‑three‑week high around $108.5 per barrel.
WTI crude advanced 2.09% to $96.37 per barrel.
The surge was driven by heightened geopolitical uncertainty after Trump called off peace talks in Islamabad, raising fresh concerns over potential disruptions in Middle East energy supply through the Strait of Hormuz.
Higher crude oil prices could stoke inflationary pressures, widen the current account deficit, and dampen corporate profitability across sectors. If Brent crude sustains above $108, it could trigger fresh selling in rate-sensitive sectors like banking and automobiles.
However, easing geopolitical tensions—even if partial—have somewhat offset the immediate impact of the crude spike. As one analyst put it: “The market could open in the green after a sharp correction in the past three to four sessions”, despite the crude headwinds.
FIIs vs DIIs: Who is Buying and Selling? {#fii-dii}
Foreign portfolio investors (FPIs) have been net sellers for five consecutive months, and that trend continued into last week. On Friday, FIIs sold shares worth ₹8,827.87 crore, while domestic institutional investors (DIIs) purchased equities worth ₹4,700.71 crore on a net basis.
The continued FII outflow is attributed to:
Global risk aversion amid the West Asia conflict
Elevated US bond yields making emerging markets relatively less attractive
Currency concerns with the rupee staying under pressure
Moody’s cutting India’s FY27 GDP growth forecast to 6%
DIIs, however, continue to step in on every dip, providing a stabilizing influence. Their sustained buying, coupled with strong SIP inflows into mutual funds, is creating a safety net that prevents sharp, sustained selloffs.
Technical Outlook: What Analysts Are Saying {#technical outlook}
From a technical perspective, Monday’s rally has helped the indices reclaim some lost ground, but analysts remain cautiously optimistic. Here’s what some experts are saying:
Amol Athawale, VP Technical Research, Kotak Securities: “77,000 would act as a crucial reference point for traders. Below this level, the correction wave is likely to continue, with Sensex potentially slipping to the 20-day SMA or 76,000. Further downside could also continue, dragging the index to the 75,700–75,500 range. On the upside, above 77,000, Sensex could bounce back up to 78,000–78,200.”
Nagaraj Shetti, Senior Technical Research Analyst, HDFC Securities: “The underlying short-term trend of Nifty 50 continues to be weak, and further declines from here could drag Nifty down to the next support of 23,500 in the short term. Immediate resistance is placed at 24,100 levels.”
Nilesh Jain, VP, Centrum Finverse: “Immediate support for Nifty is now placed at the 21-DMA around 23,580. On the retracement front, the 38.2% Fibonacci level of the recent upmove is positioned at 23,690, which could be tested in the upcoming expiry week.”
Key Technical Levels
Index | Immediate Support | Next Support | Immediate Resistance | Next Resistance |
Nifty 50 | 23,800 / 23,580 | 23,500–23,400 | 24,100 | 24,200 |
Sensex | 76,000 | 75,700–75,500 | 77,000 | 78,000–78,200 |
The India VIX (volatility index), which spiked nearly 15% last week to around 20, fell over 6% to ~18.56 levels on Monday—suggesting a reduction in near‑term market uncertainty.
Looking Ahead: Key Triggers for the Coming Days {#looking-ahead}
While the market enjoyed a breather on Monday, several critical events over the next few days could dictate the direction in the coming weeks.
1. US Federal Reserve Policy Meeting (April 28–29)
Markets are widely expecting the Fed to keep interest rates unchanged in the 3.5–3.75% range for the third straight meeting. However, the focus will be on Chairman Powell’s commentary regarding the future path of rate cuts. With core PCE inflation remaining above the 2% target and crude oil prices surging, the room for aggressive rate cuts appears limited.
2. Mega‑Cap Tech Earnings (Microsoft, Alphabet, Amazon, Meta)
The “Magnificent Seven” (Apple, Microsoft, Alphabet, Amazon, Nvidia, Meta, Tesla) are expected to post an average Q1 earnings growth of 22.8%, compared to just 10.1% for the remaining 493 S&P 500 constituents. Their performance could trigger global risk sentiment, impacting FII flows into emerging markets like India.
3. US GDP Advance Estimate and PCE Inflation Data
The advance Q1 GDP estimate and core PCE inflation data, due later this week, will provide crucial insights into the health of the US economy. Any upside surprise in inflation could further reduce the probability of rate cuts this year.
4. Continuation of Q4 Earnings Season
With quarterly results still pouring in, stock‑specific volatility is likely to remain high. Investors should closely monitor heavyweight announcements from ICICI Bank, HDFC Bank, Infosys, and TCS in the coming days.
5. Geopolitical Developments
Any further progress—or setback—in US‑Iran peace negotiations will have an outsized impact on crude oil prices and, consequently, Indian markets. The reopening of the Strait of Hormuz remains the single most important variable for energy markets.
6. FII Flows
Having been net sellers for five consecutive months, FPIs’ positioning will be critical to the sustainability of the current rally. A reversal in FII outflows—even a modest one—could provide strong legs to the upmove.
Final Verdict: Bottom Line {#final-verdict}
Monday’s sharp rebound should be interpreted as a technical pullback and value-buying rally rather than a confirmation of a sustained uptrend. While the India–NZ FTA and Sun Pharma’s acquisition are significant medium‑term positives, several headwinds remain:
Crude oil prices hovering above $107 per barrel
Persistent geopolitical uncertainty in West Asia
Continued FII outflows (₹8,827 crore net selling on Friday alone)
Volatility arising from the ongoing Q4 earnings season
That said, the strong participation from DIIs, robust SIP flows, and a resilient domestic economy provide a solid floor. Investors are advised to remain cautious and treat every sharp rally as an opportunity to accumulate fundamentally sound stocks gradually, rather than chase momentum.
As Sunny Agarwal of SBI Securities aptly summarized: “Uncertainty in the market still persists as investors await clarity on the West Asia conflict, although we believe that we may hear something very soon on the positive side with regards to the development in peace talks.”
Disclaimer: This blog is for informational and educational purposes only and does not constitute investment advice. Stock market investments are subject to market risks. Please consult your financial advisor before making any investment decisions.
.webp)
